Intuitive Surgical has forever changed the face of surgery and minted its long-term investors a fortune. Given the success of the robotic surgery pioneer, it should come as no surprise to see that many other companies are trying to duplicate the company’s business model. This includes beleaguered upstarts such as TransEnterix and Titan Medical as well as the big boys like Medtronic, Stryker, and more recently Johnson & Johnson.
However, TransEnterix and Titan Medical both remain extremely speculative investments, while at the opposite end of the spectrum, the medical device giants do not offer investors a pure-play way to bet on robotic surgery growth.
